[go: up one dir, main page]

AR054256A1 - Suplemento nutricional para una categoria de pacientes con hiv - Google Patents

Suplemento nutricional para una categoria de pacientes con hiv

Info

Publication number
AR054256A1
AR054256A1 AR20060101604A ARP060101604A AR054256A1 AR 054256 A1 AR054256 A1 AR 054256A1 AR 20060101604 A AR20060101604 A AR 20060101604A AR P060101604 A ARP060101604 A AR P060101604A AR 054256 A1 AR054256 A1 AR 054256A1
Authority
AR
Argentina
Prior art keywords
hiv
oligosaccharides
patients
nutritional
nutritional supplement
Prior art date
Application number
AR20060101604A
Other languages
English (en)
Inventor
Johan Garssen
Tol Eric Alexander Francis Van
Johannes Wilhelmus Chri Sijben
George Verlaan
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34939443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054256(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of AR054256A1 publication Critical patent/AR054256A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un producto nutricional para pacientes con HIV que no están sometidos a una Terapia Antirretroviral Altamente Activa. En forma más específica la presente se relaciona con una composicion nutricional que comprende oligosacáridos. También se describe la elaboracion de un suplemento nutricional para usar en pacientes con HIV. Reivindicacion 1: Uso de uno o más oligosacáridos, caracterizado porque dichos oligosacáridos se eligen entre: oligosacáridos ácidos preparados a partir de pectina, pectato, alginato, condroitina, ácidos hialuronicos, heparina, heparano, carbohidratos bacterianos, sialoglicanos, fucoidano, fucooligosacáridos o carragenano u oligosacáridos neutros seleccionados de grupo que consiste en galactooligosacáridos, fructooligosacáridos, transgalactooligosacáridos xilooligo-sacáridos, lactosacarosa y arabinooligosacáridos en la elaboracion de una composicion para usar en un método para el tratamiento y/o la prevencion del HIV en un sujeto humano que tiene un recuento de linfocitos CD4+ T entre 200 y 700 células/microlitro de sangre y donde dicho sujeto no está tratado con Terapia Antirretroviral Altamente Activa.
AR20060101604A 2005-04-21 2006-04-21 Suplemento nutricional para una categoria de pacientes con hiv AR054256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103260A EP1721611A1 (en) 2005-04-21 2005-04-21 Nutritional supplement with oligosaccharides for a category of HIV patients

Publications (1)

Publication Number Publication Date
AR054256A1 true AR054256A1 (es) 2007-06-13

Family

ID=34939443

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20060101604A AR054256A1 (es) 2005-04-21 2006-04-21 Suplemento nutricional para una categoria de pacientes con hiv

Country Status (14)

Country Link
US (1) US20090082249A1 (es)
EP (2) EP1721611A1 (es)
JP (1) JP2008536915A (es)
CN (1) CN101262783A (es)
AR (1) AR054256A1 (es)
AU (1) AU2006237739A1 (es)
BR (1) BRPI0610784A2 (es)
CA (1) CA2605210A1 (es)
MX (1) MX2007013082A (es)
NO (1) NO20075323L (es)
NZ (1) NZ562666A (es)
RU (1) RU2007143060A (es)
WO (1) WO2006112717A2 (es)
ZA (1) ZA200709047B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EA009076B1 (ru) * 2002-08-30 2007-10-26 Кампина Б.В. Пенообразующий ингредиент и продукты, содержащие такой ингредиент
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CN1972604B (zh) * 2004-06-22 2010-06-02 努特里希亚公司 Hiv患者中屏障完整性的提高
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
AU2006237738B2 (en) * 2005-04-21 2011-09-29 N.V. Nutricia Nutritional supplement for HIV patients
WO2008156354A1 (en) * 2007-06-21 2008-12-24 N.V. Nutricia Modulation of intestinal flora of hiv patients
WO2009096772A1 (en) 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
MX376863B (es) 2010-12-31 2025-03-07 Abbott Lab Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o niños al usar los oligosacaridos de leche humana.
SG191792A1 (en) 2010-12-31 2013-08-30 Abbott Lab Human milk oligosaccharides for modulating inflammation
WO2012092157A2 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
SG191395A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
SG10201707519PA (en) 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
WO2012177118A1 (en) * 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG11201607831TA (en) 2014-03-26 2016-10-28 Abbott Lab Nutritional supplement powder
WO2017151540A1 (en) 2016-02-29 2017-09-08 Abbott Laboratories Nutritional supplement powder

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981629A (en) * 1960-04-05 1961-04-25 Lewis F Ginnette Process of dehydrating foams
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (es) * 1973-05-21 1981-10-29
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) * 1982-06-25 1984-03-20 Societe D'assistance Technique Pour Produits Nestle S.A. Foaming creamer and method of making same
DE3734962C1 (de) * 1987-10-15 1989-01-05 Luitpold Werk Chem Pharm Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
JPH01149730A (ja) * 1987-12-07 1989-06-12 Osaka Prefecture レトロウイルス増殖抑制剤
EP0355905B1 (en) * 1988-08-24 1993-01-07 Akzo N.V. Heparin fragments and fractions with anti-hiv action
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
EP1961312A3 (en) * 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixture and uses thereof
FR2673812B1 (fr) * 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
JPH04300888A (ja) * 1991-03-28 1992-10-23 Dainippon Ink & Chem Inc カルボン酸オリゴ糖エステル硫酸化物
IT1248060B (it) * 1991-06-14 1995-01-05 Italfarmaco Spa Eparine acilate come inibitori della replicazione di retrovirus
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
US5502041A (en) * 1992-12-11 1996-03-26 The Center For Innovative Technology Potent inhibitor of HIV reverse transcriptase
US5472952A (en) * 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
DE4404877C1 (de) * 1994-02-17 1995-03-02 Ksk Industrielackierungen Gmbh Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
JPH08151328A (ja) * 1994-11-28 1996-06-11 Fuji Ratetsukusu Kk エイズ感染防止潤滑剤
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
JP2001516343A (ja) * 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
US5840361A (en) * 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
NL1005809C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Poederverfbindmiddelsamenstelling.
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
FR2781673B1 (fr) * 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) * 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
KR100647057B1 (ko) * 1999-01-28 2006-11-17 소시에떼 데 프로듀이 네슬레 소시에떼아노님 착향의 가용성 크리머 분말
EP1074181A1 (en) * 1999-08-03 2001-02-07 Societe Des Produits Nestle S.A. Foaming creamer ingredient and powders containing it
DE19940011B4 (de) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
DE10006989A1 (de) * 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) * 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
DE10027050A1 (de) * 2000-06-02 2001-12-13 Karim Balan Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en) * 2000-08-11 2002-07-30 Global Health Sciences, Inc. Low-carbohydrate high-protein creamer powder
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
CN1111541C (zh) * 2000-09-15 2003-06-18 青岛海洋大学 一种聚甘露糖醛酸硫酸盐
DE10057976B4 (de) * 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
NZ521894A (en) * 2001-02-15 2006-08-31 Adeka Corp Products containing beta-glucan
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
EA009076B1 (ru) * 2002-08-30 2007-10-26 Кампина Б.В. Пенообразующий ингредиент и продукты, содержащие такой ингредиент
WO2004026259A2 (en) * 2002-09-20 2004-04-01 Griscom Bettle, Iii Transdermal compositions
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
AU2003904192A0 (en) * 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
AU2004283628B2 (en) * 2003-10-24 2010-07-22 N.V. Nutricia Immunemodulating oligosaccharides
FR2866203B1 (fr) * 2004-02-13 2006-12-08 Roquette Freres Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
CN1972604B (zh) * 2004-06-22 2010-06-02 努特里希亚公司 Hiv患者中屏障完整性的提高
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
JP2008505912A (ja) * 2004-07-07 2008-02-28 ザ ジェネラル ホスピタル コーポレーション 全血及び血漿におけるａｔｉｉｉの直接的活性化法
WO2007015937A1 (en) * 2005-07-27 2007-02-08 Cantabria Group Lcc Phosphorytated glucomannan polysaccharides containing 1-6 and 1-2 linkages increase weight gain in swine

Also Published As

Publication number Publication date
AU2006237739A1 (en) 2006-10-26
US20090082249A1 (en) 2009-03-26
WO2006112717A3 (en) 2007-07-12
EP1721611A1 (en) 2006-11-15
WO2006112717A2 (en) 2006-10-26
ZA200709047B (en) 2008-09-25
CA2605210A1 (en) 2006-10-26
JP2008536915A (ja) 2008-09-11
NZ562666A (en) 2011-03-31
MX2007013082A (es) 2008-01-11
EP1874136A2 (en) 2008-01-09
CN101262783A (zh) 2008-09-10
RU2007143060A (ru) 2009-06-10
NO20075323L (no) 2008-01-21
BRPI0610784A2 (pt) 2010-11-09

Similar Documents

Publication Publication Date Title
AR054256A1 (es) Suplemento nutricional para una categoria de pacientes con hiv
AR054257A1 (es) Suplemento nutricional para pacientes con hiv
RU2013135311A (ru) Комбинация компонентов для профилактики и лечения немощности
ES2667033T3 (es) Viscosidad extensional para favorecer una deglución segura de los bolos de alimentos
EP2123282A3 (en) Immunemodulating oligosaccharides
NZ599748A (en) Improving memory in subjects with mini-mental state examination of 24-26
RU2012156850A (ru) Предварительно сгущенная компактная жидкая питательная композиция для пациентов с дисфагией
CN101248873A (zh) 具有视力保护功能的饮用食品
US20180333426A1 (en) Nutritional composition with human milk oligosaccharides and uses thereof
BRPI0509017A (pt) composições hmb e utilizações das mesmas
CN101163415B (zh) 用于hiv患者的营养补充剂
AU2015324390B2 (en) Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
RU2007102085A (ru) Улучшение целостности интестинального барьера
CA2919964A1 (en) Nutritional compositions for enhancing brain development
US20150290261A1 (en) Methods of use for probiotics and prebiotics
AU2014290766B2 (en) Methods for promoting neuronal development and/or health
NZ602249A (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
CN112385827A (zh) 高能量密度酪蛋白型全营养特医食品乳剂及其制备方法
CA2570208A1 (en) Improvement of barrier integrity in hiv patients
EP3373748A1 (en) Nutritional compositions comprising a casein hydrolysate, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
Allaert Effect of NaCl+ Chitosan 3% vs. NaCl on high blood pressure parameters of healthy volunteers with prehypertension
ATE424732T1 (de) Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate
WO2015094533A1 (en) Nutritional composition containing a neurologic component of ursolic acid
CL2023002452A1 (es) Composiciones y métodos que usan una combinación de oleuropeína y magnesio
US20150290260A1 (en) Methods of use for probiotics and prebiotics

Legal Events

Date Code Title Description
FB Suspension of granting procedure